SALT LAKE CITY--(BUSINESS WIRE)-- BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced today that the Cancer Treatment Centers of America (CTCA), located in Tulsa, Oklahoma, has ...
The BSD-2000/3D provides targeted deep regional therapeutic hyperthermia to solid tumors by applying radiofrequency (RF) energy. The BSD-2000/3D delivers energy to a patient using a power source and ...
SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (“BSD”) (NASDAQ:BSDM) today reported clinical study data showing that hyperthermia, using the BSD-2000 Hyperthermia System, combined with ...
BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that BSD’s exclusive ...
April 12, 2005 — The State Food and Drug Administration of the People's Republic of China has approved a deep hyperthermia system for use in combination with radiation therapy and/or chemotherapy for ...
NEW YORK (MarketWatch) -- BSD Medical on Friday said it has applied to the U.S. Food and Drug Administration for an approval of its BSD-2000 cancer treatment system. The pre market approval ...
SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced ...
BSD Medical Corp., a provider of medical systems that utilize heat therapy to treat cancer, announced that BSD's exclusive Taiwan distributor, Linden Bioscience Co. has informed BSD that the Taiwan ...
SALT LAKE CITY--(BUSINESS WIRE)-- BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, today ...
) announced today that the Company has obtained Humanitarian Device Exemption marketing approval for the BSD-2000 Hyperthermia System (BSD-2000) from the U.S. Food and Drug Administration. The ...
The BSD-2000 provides deep regional therapeutic hyperthermia to solid tumors (primarily for cervical cancer) by applying radiofrequency (RF) energy at the frequency range of 75 to 120 MHz. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results